1.Jin, Zige#; Wang, Hanling#; Tang Ruxian#; Pan Biying #; Lee, Hui-Ju; Liu, Siqi; Wang, Leiming; Qin, Jun*; Xu, Mafei*. GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity. Oncogene, 2024, 43:2595–2610. 

2.Wang, Xinrui; Jin, Zige; Tang, Shanshan; Huang, Xiyu; Wang, Shanshan; Ren, Xiaohe; Xu, Mafei. ATRX loss suppresses the type I interferon response in sarcoma cells through chromatin remodeling, American journal of cancer research, 2023, 13(8): 3547-3558

3.Jin, Zige^#; Wang, Hanling^#; Tang Ruxian^#; Pan Biying ^#; Lee, Hui-Ju; Liu, Siqi; Wang, Leiming; Qin, Jun*; Xu, Mafei*. GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity. Oncogene, 2024, 43:2595–2610. 
4.Wang, Xinrui; Jin, Zige; Tang, Shanshan; Huang, Xiyu; Wang, Shanshan; Ren, Xiaohe; Xu, Mafei. ATRX loss suppresses the type I interferon response in sarcoma cells through chromatin remodeling, American journal of cancer research, 2023, 13(8): 3547-3558
5. Mafei Xu, Jun Qin, Leiming Wang, Hui-Ju Lee, Chung-Yang Kao, Dan Liu, Zhou Songyang, Junjie Chen, Ming-Jer Tsai, and Sophia Y. Tsai. Nuclear receptors regulate alternative lengthening of telomeres through a novel non-canonical FANCD2 pathway. Sci. Adv. 2019; 5(10): eaax6366.
6. Chung-Yang Kao*, Mafei Xu*,, Leiming Wang*, Shih-Chieh Lin, Hui-Ju Lee,Lita Duraine, Hugo J. Bellen, David S. Goldstein, Sophia Y. Tsai, Ming-Jer Tsai. Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson’s disease through mitochondrial dysfunction. PLOS Genetics. 2020; 16(6):e1008868.
7. Leiming Wang, Mafei Xu, Chung-Yang Kao, Sophia Y. Tsai, and Ming-Jer Tsai. JQ1 promotes prostate cancer invasion through FOXA1 inactivation in a BET protein-independent pathway. J Clin Invest. 2019; doi: 10.1172/JCI126327
8. Leiming Wang, Chiang-Min Cheng, Jun Qin, Mafei Xu, Chung-Yang Kao, Jingjing Shi, Erli You, Wanchun Gong, Laura Pedro Rosa, Peter Chase, Louis Scampavia, Franck Madoux, Timothy Spicer, Peter Hodder, H. Eric Xu, Sophia Y. Tsai, and Ming-Jer Tsai. The use of small molecule inhibitors targeting orphan nuclear receptor COUP-TFII for prostate cancer treatment. Sci. Adv. 2020;6(18):eaaz8031
9. Hui-Ju Lee, Chung-Yang Kao, Shih-Chieh Lin, Mafei Xu, Xin Xie, Sophia Y. Tsai and Ming-Jer Tsai. Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. Sci Rep. 2017;7(1):3136.
10. Leiming Wang, Mafei Xu, Jun Qin, Shih-Chieh Lin, Hui-Ju Lee, Sophia Y. Tsai, and Ming-Jer Tsai. MPC1, a key gene in cancer metabo-lism, is regulated by COUPTFII in human prostate cancer. Oncotarget.2016;7(12):14673-83.
11. Mafei Xu, Jun Qin, Sophia Y. Tsai, and Ming-Jer Tsai. The role of the orphan nuclear receptor COUP-TFII in tumorigenesis. Acta Pharmacol Sin. 2015;36(1):32-6.
12. Daniëlle G.M. Bosch*, F. Nienke Boonstra*, Claudia Gonzaga-Jauregui*, Mafei Xu, Joep de Ligt, Shalini Jhangiani, Wojciech Wiszniewski, Donna M. Muzny, Helger G. Yntema, Rolph Pfundt, Lisenka E.L.M. Vissers, Liesbeth Spruijt, Ellen A.W. Blokland,Chun-An Chen, Baylor-Hopkins Center for Mendelian Genomics, Richard A. Lewis, Sophia Y. Tsai, Richard A. Gibbs, Ming-Jer Tsai, James R. Lupski, Huda Y. Zoghbi, Frans P.M. Cremers, Bert B.A. de Vries and Christian P. Schaaf. NR2F1 mutations cause optic atrophy with intellectual disability. Am J Hum Genet. 2014;94(2):303-9.
13. Mafei Xu, Fang Zhang, Liang Da, Tsaiping Li, Mujun Zhao. Microspherule protein 2 associates with ASK1 and acts as a negative regulator of stress-induced ASK1 activation. FEBS Lett. 2012;586(12):1678-86.
10. Guoyuan Chen, Liang Da, Ying Xu, Mafei Xu, Li Song, Tsaiping Li, Mujun Zhao. C-terminal amino acids 290-328 of LPTS/ PinX1 confer telomerase inhibition. Biochem Biophys Res Commun. 2010;398(4):683-9.
14. Chengfu Sun, Mafei Xu, Zhen Xing,  Zhili Wu, Yiping Li, Tsaiping Li, Mujun Zhao. Expression and function on embryonic development of lissencephaly-1 genes in zebrafish. Acta Biochim Biophys Sin (Shanghai). 2009 Aug;41(8):677-88.